161 PSMA-PET Guided Intensification of Radiotherapy for Prostate Cancer: Preliminary Detection Rate and Impact on Radiotherapeutic Management
Cynthia Ménard(University of Toronto), Fred Saad(Centre Hospitalier de l’Université de Montréal), David Roberge(Centre Hospitalier de l’Université de Montréal), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), Jean-Paul Bahary(Université de Montréal), Daniel Taussky(Centre Hospitalier de l’Université de Montréal), Daniel Juneau(Wake Forest University), Philip Wong(Unknown), Maroie Barkati(Centre Hospitalier de l’Université de Montréal), Tibor Schuster(Technical University of Munich), Marie-Claude Beauchemin(Centre Hospitalier de l’Université de Montréal), Guila Delouya(Centre Hospitalier de l’Université de Montréal)
Cited by 0
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k